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Abstract: In the last decades bioresorbable and biodegradable polymers have gained a very good
reputation both in research and in industry thanks to their unique characteristics. They are able
to ensure high performance and biocompatibility, at the same time avoiding post-healing surgical
interventions for device removal. In the medical device industry, it is widely known that product
formulation and manufacturing need to follow specific procedures in order to ensure both the proper
mechanical properties and desired degradation profile. Moreover, the sterilization method is crucial
and its impact on physical properties is generally underestimated. In this work we focused our
attention on the effect of different terminal sterilization methods on two commercially available
poly(L-lactide-co-ε-caprolactone) with equivalent chemical composition (70% PLA and 30% PCL)
and relatively similar initial molecular weights, but different chain arrangements and crystallinity.
Results obtained show that crystallinity plays a key role in helping preserve the narrow distribution of
chains and, as a consequence, defined physical properties. These statements can be used as guidelines
for a better choice of the most adequate biodegradable polymers in the production of resorbable
medical devices.
Keywords: electron beam; ethylene oxide; medical devices; polymers; sterilization
1. Introduction
Biodegradable polymers have become, in the last decade, a major base material for the
development of many different bioresorbable medical devices [1–3]. Thanks to their intrinsic
characteristics and chemical and physical nature, they perfectly match with this kind of specific
application, as they ensure high performance, complete biocompatibility, and tunable resorbability at
the same time [4–6].
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Indeed, playing with the initial composition of polymers and their molecular weights,
mostly derivatives of polylactic acid (PLA), of polyglycolic acid (PGA) and of polycaprolactone
(PCL), and/or their copolymers and blends, enables them to perfectly combine desired mechanical
characteristics with a fully bioresorbable product [7,8]. Specifically, they properly address the big
disadvantage of the post-healing surgical intervention for devices that need to be implanted into the
patient’s body [9], because, upon degradation, they will be naturally eliminated by the organism
without necessity of direct removal [10–12].
These considerations, coupled with the intrinsic ease of processing and the production of
polymer-based building blocks, both in the form of individual polymer chains [13] or in the micro and
nanoparticles fashion [14–16], make them a very robust path towards the development of advanced
medical devices and controlled drug delivery systems. Indeed, many different applications have
been properly exploited and developed, from biodegradable suture systems [17], to polymer capsules
for drug delivery application [14], hydrogels [18] for controlled drug release, and scaffolds for cells
in tissue engineering [19]. As mentioned before, the great advantage that all of the aforementioned
products have in common is that they will naturally disappear from the patient’s body in reasonable
and controllable time after the implantation, leaving minimal traces and small impact [1].
When dealing with implantable medical devices, it is very important to point out that, in industrial
practice, product formulation and manufacturing need to follow specific procedures. Indeed, once the
desired inputs are defined (i.e., mechanical properties and degradation profile) accurate selection of
the base material needs to be done. This has to take into consideration not only the characteristics
of the pristine base polymer but also the way they will be affected by all the manufacturing and
post-processing steps.
As a matter of fact, processes such as thermoforming, injection molding, extrusion and in
general all of those that are performed at medium to high temperature and/or applying mechanical
stress can significantly alter the polymers features [20]. Moreover, though some steps might be
product dependent, certainly terminal sterilization represents in this sense not only a major point,
but also a crucial, necessary, and compulsory passage in the production of every implantable medical
device [21,22]. Specifically, it aims at the inactivation of any microbiological contaminants that might
be present on the final products. Moreover, although preparation conditions might be perfectly in
accordance with quality management system guidelines (i.e., ISO 13485-2016), the finite outputs can
be considered sterile only if they are free from any viable microorganisms [23,24]. The necessity on
relying on a fully validated and fixed protocol, ensuring reliable and reproducible performances,
therefrom derives.
The most widely used industrial terminal sterilization techniques imply either steam, ethylene oxide
(EtO), γ or electron beam irradiation [25]. Regarding polymer-based devices, not all of the
aforementioned possibilities are available as, for example, steam and γ irradiation frequently cause
excessive degradation and changes in physical or mechanical properties, which can be detrimental
for intended performance, especially in terms of degradation rates and times and also device shapes
and dimensions [24,25]. Thus, the most conventional solutions in this sense involve electron beam
radiations and exposition to alkylation agents (e.g., ethylene oxide) [23].
Apart from the composition and the molecular weights (Mw, Mn, PD), that clearly have a
role in polymer response to all manufacturing and post-processing operations [20,26], and are
generally taken into consideration in product formulation, often also other crucial physical
parameters (Tg, Tm, crystallinity) [27,28], might be of great interest, though many times neglected.
A superficial characterization generally leads to major issues when different raw material suppliers or
formulations are required, especially because the final response to the whole production processing,
including sterilization, might not be identical [29].
In this work we decided to study the effect of the two most common different terminal
sterilization methods for resorbable biopolymers (EtO and electron beam) on two commercially
available poly(L-lactide-co-ε-caprolactone) with equivalent chemical composition (70% PLA and
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30% PCL) and relatively similar initial molecular weight, but with different chain arrangements
and crystallinity.
These polymers find application in the production of devices for hard tissues fixation and
regeneration [30–32]. As a matter of fact, it resulted that crystallinity, indeed, plays a role in the
response of these apparently equivalent polymers to different sterilization techniques, helping in
preserving the narrow distribution of chains and, as a consequence, defined physical properties.
Furthermore, we employed independent experimental data from the literature in order to quantify the
impact of the sterilization on the actual degradation rate through mathematical modeling.
As an outcome, we identified two major points to be taken into consideration in the formulation
of polymer-based medical devices: first, the importance of establishing the impact of the selected
terminal sterilization methodology on the polymeric material itself; second, the characterization of the
base polymer cannot simply focus on the molecular weight and chemical composition but needs to be
extended to other physical parameters. These statements can be used as guidelines for the usage of
biodegradable polymers in the production of bioresorbable medical devices.
2. Materials and Methods
2.1. Materials
The following chemicals have been used as supplied, without further treatment:
poly(L-lactide-co-ε-caprolactone) purchased as PLC 70 from Purac-Corbion (Amsterdam,
The Netherlands), named from now on polymer P; poly(L-lactide-co-ε-caprolactone) purchased as
RESOMER® LC 703 S (Evonik, Essen, Germany), named from now on polymer E; tetrahydrofuran
(THF) and deuterochloroform (CDCl3) (Sigma Aldrich, Steinheim, Germany).
2.2. Terminal Sterilization Procedures
Sterilization of a product is properly intended to remove all the living microorganisms contained
in or adhering to it, including their resistant dormant bodies, such as spores [23]. When dealing with
medical devices this passage is often referred to as terminal, because it occurs on the fully finished
product, already packed and ready to be sold. A major consequence of this is the impossibility of
analytically testing again each individual device as it would mean removing the packaging and
indirectly invalidating the previous sterilization, making all the previous operations useless. Therefore,
it is necessary to imply a consolidated, reliable, and validated protocol, based on routinely monitored
procedures and equipment, which must ensure full sterilization and limited damage on the product.
Thus, the selected sterilization conditions must take into consideration, on one hand the number and
resistance of microorganisms in the environment in which the treatment is performed and on the
other hand the necessity of limited interference with the initial desired characteristics of the final
product. All sterilization protocols involved in this work have been conducted in accordance to the
aforementioned requirements and are the actual ones currently in use for conventional protocols in the
production of biodegradable polymer-based medical devices.
2.2.1. Ethylene Oxide Processing
Sterilization via EtO has been performed on both P and E polymers, following a validated
protocol, in accordance with the guidelines described in detail in ISO 11135. These procedures
take into consideration manufacturing conditions, construction materials and product design,
including geometric variability and packaging characteristics (i.e., the container must have good
EtO permeability).
The physical performance qualification allows the verification of the cycle reproducibility as well
as the evaluation of the cycle impact on the product, packaging functionality and safety. Specifically,
the samples, packed into a sealed, sterile plastic bag and aligned in a rack within a carton box are
firstly pre-conditioned for a time range of 105–170 min at a temperature range of 48–52 ◦C. After the
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cycle starts, it first reaches vacuum within a time range of 60–120 min at a temperature in the range of
48–52 ◦C, then the product is exposed to EtO in gas form for a time of 345–375 min, consistently at the
previous temperature and a humidity higher than 60%. The concentration of the gas in this phase is in
the range of 320–322 g/mc. This last passage is performed at least three times. Finally, a degassing
step of 1425–1455 min at temperature of 41–51 ◦C is performed.
2.2.2. Electron Beam Processing
Electron beam sterilization has been applied following a procedure approved and described in the
standard ISO 11137. Samples, sealed in glass vials, closed with a plastic stopper and an aluminum cap
and housed in a carton box, were passed through the chamber for a few minutes at 47.4 ◦C and invested
by a radiation dose in the range of 25–30 kGy. As the beam hits the samples, electrons penetrate the
cardboard box and all the samples in their individual packages inside the carton [23]. This ensures that
harmful microorganisms are completely inactivated. More specifically, as the electrons penetrate the
products, the radiation dose diminishes, therefore, in reality, less radiation leaves the box then entered.
Thus, the boxes are usually turned over and irradiated again from the opposite side in order to get a
relatively uniform dose.
2.3. Analytical Methods
Polymer samples have been characterized both before and after each sterilization procedure using
the analytical techniques presented as follows.
2.3.1. Gel Permeation Chromatography
Weight-average (Mw) and number-average molecular weight (Mn) values and molecular weight
distributions (Mw/Mn) values of the polymers were evaluated using a Jasco LC-2000Plus gel
permeation chromatograph (GPC) equipped with a refractive index detector RI-2031Plus (Jasco,
Oklahoma City, OK, USA) using 3 Agilent (Santa Clara, CA, USA) PLgel columns, 5 × 10−6 m
particle size, 300 × 7.5 mm (Mw range: 5 × 102 to 17 × 105 g·mol−1). THF was chosen as eluent
at a flow rate of 0.5 mL·min−1 at 35 ◦C. The GPC samples were injected using a Jasco AS-2055Plus
autosampler. The instrument was calibrated using polystyrene standards from 580 to 3,250,000
Da (Polymer Laboratories, Church Stretton, UK). Probes have been run in duplicates, showing full
consistency and overlapping of the data.
2.3.2. Differential Scanning Calorimetry
Differential scanning calorimetry (DSC) measurements were conducted using Q1000 Differential
Scanning Calorimeter (TA Instruments, New Castle, DE, USA) using 40 µL crucibles in aluminum and
a heating and cooling rate of 5 ◦C·min−1 in a nitrogen atmosphere (T ranges: 0–200 and 0–300 ◦C).
Probes have been run in triplicates, showing full consistency and overlapping of the data.
2.3.3. X-ray Diffraction
The crystal structure was investigated by the grazing incident X-ray diffr PLgel columns,
5 × 10−6 m particle size, 300 × 7.5 mm action (XRD) (Malvern Panalytical, Malvern, UK) technique
with Cu Kα radiation in Bragg-Brentano configuration with the scanning angle of 3◦. Probes have been
run in duplicates, showing full consistency and overlapping of the data.
2.3.4. Nuclear Magnetic Resonance (1H-NMR)
Nuclear Magnetic Resonance (1H-NMR) was run on samples prepared by dissolving 50 mg of
species of interest in 3 mL in CDCl3 and analyzed with H-NMR 300 MHz from Bruker (Billerica, MA,
USA). Probes have been run in duplicates, showing full consistency and overlapping of the data.
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3. Results and Discussion
3.1. Prystine Polymer Characterization
In this section, the characterization of the two pristine polymers is reported. In Figure 1 the GPC
chromatograms for both polymer P and E are visible and the characterization results, including also
the other analytical techniques, are presented in Table 1. As is evident, their initial molecular weight is
relatively high in both cases, and the NMR spectra (Figure S1 in S.I.) shows full consistency in their
composition, which is confirmed equal to the one declared by the suppliers of 70% PLA and 30% PCL
(full data in Table 1).
On the other hand, still NMR, DSC (Figure 2) data, and XRD enable us to identify considerable
differences between the two polymers (data in Table 1). As a matter of fact, E polymer has a crystallinity
degree of 65% whereas P is around 35%. This statement is well supported by the NMR and DSC
curve of Figure 2. Indeed, polymer E presents a well for the crystallization temperature, at 106 ◦C,
and a defined melting point at 160 ◦C, whereas polymer P does not show any of the aforementioned
detectable points and the shape of the curve clearly resemble one of the amorphous polymers. A similar
conclusion can be drawn when looking at the XRD measurement (Figure S2 in S.I.) that also confirms
the partial crystalline nature of E and the amorphous one of P. Indeed, from the Scherrer equation
we calculated full width at half maximum (FWHM) and average grain size (Lhkl) [33] and the more
crystalline nature of E sample is evident. Therefore, though the two polymers might look similar
from the composition and up to certain extent also from the molecular weight perspective, it is
nonetheless reasonable to expect different physical behavior and response to the sterilization protocols
in dependence of their crystallinity.
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Table 1. Data obtained by GPC, Nuclear Magnetic Resonance (1H-NMR), differential scanning
calorimetry (DSC), and X-ray diffraction (XRD) of the polymeric samples.
GPC 1H-NMR DSC XRD







E 119,600 85,660 1.12 25.4 61.1 65 4.5 0.308
P 172,750 123,800 1.6 25.5 36.1 35.2 7.5 0.185
E EtO 96,000 78,700 1.2 25 59.6 60 4.5 0.308
P EtO 159,400 97,300 1.64 25.7 34.3 35 7.5 0.185
E e-beam 51,800 43,660 1.3 25.6 60.6 59.2 4.5 0.317
P e-beam 133,300 64,100 2.08 25.4 35.5 32.1 7.5 0.185
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3.2. Ethylene Oxide Processing
Though relatively expensive, EtO processing is widely used for the sterilization of medical devices
and surgical instruments and it basically consists of a controlled exposure of the products to EtO in
gaseous form, in a sealed chamber. The high diffusivity of EtO, coupled with its high reactivity, is of
major importance for the inactivation of microorganisms. In fact, EtO can penetrate selected packaging
and access all the exposed surfaces of the product. Moreover, it works as an alkylating agent for protein
essential for cell reproduction, DNA, and RNA. This way, it prevents normal cellular metabolism
and the ability to reproduce of the affected microbes, which becomes nonviable [24]. In general,
the chemical species targeted by EtO are not included in most of the medical devices’ composition,
therefore, their exposure to EtO should have very little or no impact on them, independently of their
physical characteristics. On the other hand, the whole process is performed at mid-high temperature
and relatively high humidity, both parameters that might affect the polymer initial fashions. Indeed,
though not great changes are recorded in the physical characteristics of the polymers (DSC in Figure 3,
NMR in Figure S3 and XRD in Figure S4 in S.I.), still a statistically relevant albeit small reduction of
the molecular weights is recorded for both of them (Table 1). As a matter of fact, the Mw of polymer E
moves from 119,609 to 96,000 Da, with a change in PD of 0.013, whereas the one of polymer P shifts
from 172,746 to 159,413 Da with a PD variation of 0.04 (Figure 4). Though these changes might not be
an effect of the EtO directly, it is anyhow rather important to record the inevitable degradation effect
given by the whole sterilization protocol.
3.3. Electron Beam Processing
Electron beam irradiation processing (e-beam) is commonly used in the sterilization of medical
devices and in general represents a much faster and cheaper solution in respect to EtO processing.
The procedure involves irradiation of the products with a high-energy electron beam, which ionizes
in a controlled way the hit samples. The bombardment results in a cascade of free electrons through
the material domain, which, when interacting with surrounding molecules, generates free radicals.
These last species induce breaks in the DNA double helix, preventing replication and expression,
therefore enabling sterilization effects [23]. Due to its mechanism of action, it is important to limit
the duration of the whole irradiation to the minimum (generally just few minutes), otherwise great
damage on the final products, such as polymers embrittlement, oxidative damage, and color change
might occur [34,35]. Indeed, especially for polymer based devices, ionizing radiations exhibit an
important side effect that affects their performance, such as a decrease in both number and weight,
average molecular weight, and modification of the chains distribution and conformation.
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Such an effect is evident already at the minimal radiation dose (the “overkill dose”) that ensures
sterilization, equal to 25 kGy [36]. Indeed, the free radicals and ions can also lead to recombination
reactions, hydrogen abstraction or cross-linking reactions [37]. Moreover, if radiation energy is
higher than intramolecular forces, unzipping reactions (i.e., depolymerization reactions) can occur.
Generally speaking, the molecular weight decrease is proportional to the radiation dose [37–39].
Moreover, the specific trend depends on material composition (which determines the reactions
pathways), degree of crystallinity, and sterilization environment (i.e., temperature and the presence
of air, since oxygen molecules enhance the molecular weight decrease). This phenomenon has an
important impact on the final behavior of devices made of aliphatic polyesters, which in general
reflects on the mechanical properties of the finite device. Indeed, though the Young modulus decreases
very slightly, the elongation at break diminishes dramatically, following a dose-dependent trend.
In addition, radiations also influence the glass transition temperature, melting temperature, and the
degree of crystallinity [38,40–42].
In general, the two main reactions that take place during irradiation are chain scission and
cross-linking [26,28,38,43]. The ratio between methylene and ester groups CH2/COO is a very
important parameter, because it discriminates the structure of the material after irradiation dose [38].
In particular, for high values of CH2/COO ratio cross-linking is the dominant kinetic mechanism,
while at low values polymer degradation mainly occurs.
In particular, polyglycolic acid exhibits the lowest CH2/COO ratio and experiences degradation
while irradiated; cross-linking reactions appear only after very high radiation doses. Regarding the
considered example of poly(L-lactide-co-ε-caprolactone), as one can see from Table 1, a clear decrease
after irradiation in molecular weight Mw for both polymers E and P is observable. Indeed, the final
values are 51,814 Da for E and 133,265 Da for P. In this sense, this is a huge difference in respect to the
previously discussed EtO sterilization treatment. Moreover, though the variation of polymer P might
appear to be smaller than the case of E, this result has to be taken into consideration in light also of
the PD values of both distributions. As evident from Table 1 it varies considerably between the two
polymers: E shows a variation of 0.113 whereas P one of 0.48. This means, that in the case of P much
more oligomers are produced upon irradiation so that the distribution considerably enlarges. Therefore,
clearly it would be more difficult, from a process perspective, to rely on the selected initial properties
of the pristine material. On the other hand, polymer E almost preserves its intrinsic polydispersity,
making the effect of the treatment on the final properties of the finished device more easily predictable.
The difference that is observed within the two ionized polymers can be explained by the mechanism
of action of the radical species. Indeed, if they find themselves confined in close proximity within
the highly-ordered arrangement of chains (“cage”) in the crystalline domain it is easier for them to
recombine rather than diffuse out and propagate, reducing the effective chain scissions and making it
occur in a rather more controlled way within the crystalline domain. On the other hand, such a “cage
effect” is certainly less expected for amorphous arrangements, where much more free space is left to
the radicals to diffuse and propagate randomly through the overall polymer network [28,43].
Moreover, though the actual composition is left untouched (NMR in Figure S5 and XRD in
Figure S6 in S.I.) detectable modifications are recorded also in the crystallinity of the two polymers
upon irradiation. Indeed, the crystallinity degree of E is reduced and the actual well for the point of
crystallization is shifted from 100 ◦C for the pristine polymer to 87 ◦C for the ionized one. Such changes
are not easy to detect for the case of P, as already in its pristine appearance, it presents an amorphous
nature, whose DSC curve does not present any noticeable wells or peaks (Figure 3).
3.4. Mathematical Modelling
Electron beam sterilization not only alters the initial polymer properties, but also accelerates
the degradation rate. This cannot be disregarded, because a faster decay of the molecular weight
reduces the time span where a device can assure the desired mechanical properties. Therefore,
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a comprehensive overview of the consequences of electron beam sterilization should couple the
analysis of the detrimental effects on raw material as well as its accelerated degradation.
For this purpose, mathematical modeling emerges as a useful tool that can provide a quantitative
estimation of the molecular weight decay. In this framework, the model proposed by Perale et al. [44]
and Casalini et al. [45] has been chosen for the comprehensive description of the involved phenomena
(hydrolysis, autocatalysis, and transport phenomena) and its validated results. Details are extensively
discussed in previous papers [44,45], but model formulation is here summarized for the sake
of completeness.
The model is based on population balances, where a mass balance for a polymer chain with n
repeating units is written. Since it is necessary to write an equation for each considered chain length
value, this approach would imply a large number of differential equation to be solved (about 105).
In order to reduce the computational effort, the method of the statistical moment is employed [46],
allowing to reduce the large number of population balance equations to three equations, which accounts
for the time and spatial evolution of the statistical moments of the first three orders.






where n is chain length and Cn is the concentration of a polymer chain with n repeating units.
Under the assumption that only oligomers up to nonamers can diffuse through polymer matrix,
model is composed by a system of partial differential equations that account for time and spatial
evolution of monomer (Equation (2)), water (Equation (3)), oligomers (Equation (4)) and statistical
moments of zero-th, first and second order (Equations (5)–(7)):
∂CM
∂t
= ∇(DM∇CM) + 2kdCW(µ0 − CM)µ0 (2)
∂CW
∂t
= ∇(DW∇CW)− kdCW(µ1 − µ0)µ0 (3)
∂Cn
∂t



































where CM is monomer concentration, DM is monomer diffusion coefficient, kd is degradation kinetic
constant, CW is water concentration, DW is water diffusion coefficient, Cn is the concentration of an
oligomer with n repeating units and Dolig is oligomer diffusion coefficient.
The model takes into account the increase of diffusivity due to degradation (chain scissions open
new and wider diffusive path) through the following expression:







i = monomer, oligomer, water (8)
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where Di0 is the diffusion coefficient of the i-th species before degradation onset, and x is a generic
spatial coordinate.
The average properties of interest, such as number average molecular weight Mn, weight average














where Mmon is the molecular weight of the repeating unit.
Model equations are here written in their general form, but only one spatial coordinate (the
characteristic diffusion length) is usually considered in the Laplacian term. The system of partial
differential equations constituted by Equations (2)–(7) is solved through the method of lines: spatial
derivatives are approximated through a finite difference scheme (centered formulation) and the
resulting system of ordinary differential equations is numerically integrated by means of the ode15s
algorithm implemented in MATLAB.
The analysis has been performed starting from experimental data taken from Loo et al. [26],
chosen as a reference case for their exhaustiveness. In particular, Loo and coworkers studied the
influence of the irradiation dose on the initial properties and the hydrolytic degradation of the electron
beam-irradiated films of polylactic acid.
The mathematical model has been used in order to compute a degradation kinetic constant,
which offers a quantitative estimation of the degradation enhancement provided by electron beam
sterilization; film thickness has been considered as characteristic diffusion length.
Kinetic constants have been obtained through fitting of experimental data, in order to best
reproduce the decay of the number average molecular weight over time; data fitting has been
carried out by means of lsqnonlin algorithm implemented in MATLAB. Model input parameters
are summarized in Table 2.
Table 2. Model input parameters.






Initial conditions and kinetic constants are summarized in Table 3, while a comparison between
model results and experimental data is shown in Figure 5A.
Table 3. Initial properties of the polymer analyzed through mathematical modeling and degradation
kinetic constants obtained through experimental data fitting.
Radiation Dose
(Mrad)






0 406,000 1.60 3.85 × 10−5
5 64,700 1.68 1.27 × 10−4
10 43,200 1.73 1.47 × 10−4
20 23,100 1.76 1.21 × 10−4
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Figure 5. Comparison between model predictions (continuous line) and experimental data (filled
circles) taken from Loo et al. [26] for different radiation doses (A). Normalized degradation kinetic
constants as a function of radiation dose. Values have been normalized with respect to the kinetic
constant of the non-irradiated polymer (B).
Model best fitting is in good agreement with the experimental data, thus confirming the
reliability of the chosen approach. The obtained kinetic constants are listed in Table 3, while the
normalized values are shown in Figure 5B. In particular, values have been normalized, choosing the
non-irradiated polymer as a reference value. In primis, data confirm that electron beam sterilization
accelerates polymer degradation, since it reduces the initial molecular weight through chain scission.
According to model results, hydrolysis is about 3.5 times faster for the irradiated polymer; in addition,
degradation enhancement does not depend on radiation dose, since the values of the kinetic constants
are close to each other.
This analysis highlights that, for an optimal device design, the initial molecular weight drop due
to irradiation must be coupled with the enhanced degradation in order to identify the most suitable
polymer. In other words, the choice of the raw material (i.e., before sterilization and processing)
should take into account that the initial molecular weight will be not only reduced by processing and
sterilization but will also decay faster. This is essential for those applications where the device must
assure mechanical stability in a determined time span.
4. Conclusions
In this work we presented a case study for showing a possible methodologic approach for
the selection of appropriate biodegradable polymers in product formulation for medical devices
manufacturing. In particular, the major effect of the finished product terminal sterilization is discussed
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and a comparison between the EtO and e-beam treatments is presented for two apparently similar
poly(L-lactide-co-ε-caprolactone) base materials with identical composition (70% PLA and 30% PCL).
Specifically, the major difference resembles in the degree of crystallinity of the aforementioned
polymer: E has a relatively high degree of 65% whereas P has a rather amorphous structure.
Once sterilized, independently on the implied sterilization protocol, both polymers exhibited
degradation. Actually, the EtO exposition minimally affected the initial characteristics (in terms
of Mw, PD and crystallinity), whereas major differences before and after the treatment was observed
for e-beam irradiation. Indeed, a major reduction in molecular weight was observed for both
polymers. Additionally, the different chains arrangement led to different responses to the treatment.
Indeed, even if polymer P degraded apparently less than polymer E, the chain length distribution
considerably broadened. This would reflect in a more uncontrolled change in the desired initial
properties selected during product formulation and design. Moreover, irradiation has also a major
effect on the degradation kinetic of polymers. This effect has been studied through a mathematical
model, which allowed to identify that hydrolysis is about 3.5 times faster for the irradiated polymer
than the pristine one, remarkably not being dependent on the radiation dose.
As a conclusion, we believe that the presented example might be very useful in the development
of bioresorbable devices. As a matter of fact, intrinsic response of the material upon the overall
post-processing steps might be understood only upon a deep and appropriate characterization of the
starting polymers, even when they are nominally similar.
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beam irradiation.
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